// App-Quantinova.ai

PO1884 : Targeted B-Cell Depletion with Rituximab in Adult Relapsing Minimal Change Disease

Researchers

Presenter

  • Dattani Rakesh

Principal Investigators

  • Cairns Tom

  • Condon MarieB

  • Levy JeremyB

  • Lightstone Liz

  • McAdoo StephenPaul

  • Tam FrederickW.K

  • Griffith Megan

Medical Centers

  • Imperial College NHS Healthcare Trust London London United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Minimal change disease

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved